QSI Quantum-Si incorporated
USHealthcareAs of 2026-07-10 16:00
Why QSI matters now
Quantum-Si incorporated (QSI) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.88 with -8.28% on the session and $174.6M in market capitalization; recent performance reads 1-month +16.03% and YTD -9.18%.
The latest financial table shown here is Q1 2026, with revenue of $258.0K, net income of $-21.7M, and EPS of $-0.10. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -48.4%.
The latest indexable market news headline is "Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)" from Business Wire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $1.00; recent insider activity includes Kummeth Charles R. filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
1.08
P/S
106.71
EV/EBITDA
-1.67
DCF Value
$0.10
FCF Yield
-48.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
40.0%
Operating Margin
-5199.8%
Net Margin
-5605.9%
ROE
-47.3%
ROA
-48.7%
ROIC
-47.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $258.0K | $-21.7M | $-0.10 |
| Q4 2025 | $451.0K | $-17.6M | $-0.08 |
| FY 2025 | $2.4M | $-101.3M | $-0.51 |
| Q3 2025 | $552.0K | $-35.7M | $-0.17 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$1.00
Target (Median)
$1.00
Target Range
$1.00 - $1.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
3.17
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.